Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet

Metabolic Brain Disease

Volumn 31, Issue 2, 2016, Pages 273-278

  Endreffy, Ildikó ^a   Bjørklund, Geir ^b   Dicső, Ferenc ^a   Urbina, Mauricio A ^c,d   Endreffy, Emőke ^e  

^a Department of Hematology   (Hungary)

^b Department of Research   (Norway)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d UNIVERSITY OF CONCEPCIÓN   (Chile)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Autism; Epigenetics; Glycosaminoglycans; Neurodevelopment disorders; Nutrition; Proteoglycans

Indexed keywords

ACID GLYCOSAMINOGLYCAN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; HEPARAN SULFATE; HYALURONIC ACID; KERATAN SULFATE; URONIC ACID; GLYCOSAMINOGLYCAN;

ADOLESCENT; ARTICLE; AUTISM; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL SUPPLEMENTATION; POTENTIAL DIFFERENCE; SEX DIFFERENCE; URINALYSIS; VITAMIN SUPPLEMENTATION; CENTRAL NERVOUS SYSTEM; DIET; DIETARY SUPPLEMENT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; AUTISM SPECTRUM DISORDER; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; DIET; DIETARY SUPPLEMENTS; FEMALE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; MALE;

EID: 84961167965     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-015-9745-2     Document Type: Article

References (31)

1. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) 8:34. doi:10.1186/1743-7075-8-34
2. APA - American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington
3. Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42–77. doi:10.1016/j.brainres.2010.11.078
4. Bjørklund G (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp (Wars) 73:225–236
5. Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR (2013) Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. National health statistics reports; no 65. National Center for Health Statistics, Hyattsville
6. CDC - Centers for Disease Control and Prevention (2012) Prevalence of autism spectrum disorders–autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ 61(3):1–19
7. Chauhan A, Chauhan V, Brown WT, Cohen I (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci 75:2539–2549
8. Dauncey MJ (2013) Genomic and epigenomic insights into nutrition and brain disorders. Nutrients 5:887–914. doi:10.3390/nu5030887
9. Di Ferrante NM (1967) The measurement of urinary mucopolysaccharides. Anal Biochem 21:98–106
10. Dolinoy DC, Weidman JR, Jirtle RL (2007) Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23:297–307
11. Endreffy I, Dicsö F (1988) Glycosaminoglycan excretion in connective tissue diseases. Clin Biochem 21:135–138
12. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R (2010) Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry 19:169–78. doi:10.1007/s00787-009-0076-x
13. Irie F, Badie-Mahdavi H, Yamaguchi Y (2012) Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc Natl Acad Sci U S A 109:5052–5056. doi:10.1073/pnas.1117881109
14. Jalili M, Pati S, Rath B, Bjørklund G, Singh RB (2013) Effect of diet and nutrients on molecular mechanism of gene expression mediated by nuclear receptor and epigenetic modulation. Open Nutraceuticals J 6:27–34. doi:10.2174/1876396020130419002
15. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611–1617
16. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141B:947–956
17. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW (2009) Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89:425–430. doi:10.3945/ajcn.2008.26615
18. Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262
19. Kantor DB, Chivatakarn O, Peer KL, Oster SF, Inatani M, Hansen MJ, Flanagan JG, Yamaguchi Y, Sretavan DW, Giger RJ, Kolodkin AL (2004) Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44:961–975
20. LaSalle JM (2014) Epigenomic strategies at the interface of genetic and environmental risk factors for autism. J Hum Genet 58:396–401. doi:10.1038/jhg.2013.49
21. Li SO, Wang JL, Bjørklund G, Zhao WN, Yin CH (2014) Serum copper and zinc levels in individuals with autism spectrum disorders. Neuroreport 25:1216–1220. doi:10.1097/WNR.0000000000000251
22. Lord C, Rutter M, Le Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659–685
23. Macedoni-Lukšič M, Gosar D, Bjørklund G, Oražem J, Kodrič J, Lešnik-Musek P, Zupančič M, France-Štiglic A, Sešek-Briški A, Neubauer D, Osredkar J (2015) Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders. Biol Trace Elem Res 163:2–10. doi:10.1007/s12011-014-0121-6
24. Pearson BL, Corley MJ, Vasconcellos A, Blanchard DC, Blanchard RJ (2013) Heparan sulfate deficiency in autistic postmortem brain tissue from the subventricular zone of the lateral ventricles. Behav Brain Res 243:138–145. doi:10.1016/j.bbr.2012.12.062
25. Pérez M, Wandosell F, Colaço C, Avila J (1998) Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. Biochem J 335(Pt 2):369–374
26. Rangasamy S, D’Mello SR, Narayanan V (2013) Epigenetics, autism spectrum, and neurodevelopmental disorders. Neurotherapeutics 10:742–756. doi:10.1007/s13311-013-0227-0
27. Ray B, Long JM, Sokol DK, Lahiri DK (2011) Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One 6, e20405. doi:10.1371/journal.pone.0020405
28. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC (2008) Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ Health Perspect 116:1547–1552. doi:10.1289/ehp.11338
29. Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK (2006) High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol 21:444–449
30. Whiteman P (1973) The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX. Biochem J 131:351–357
31. Yamaguchi Y, Inatani M, Matsumoto Y, Ogawa J, Irie F (2010) Roles of heparan sulfate in mammalian brain development current views based on the findings from Ext1 conditional knockout studies. Prog Mol Biol Transl Sci 93:133–152. doi:10.1016/S1877-1173(10)93007-X